Search results
Decoding Avantor Inc (AVTR): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 4 months agoAvantor Inc's strong market presence in the Americas, Europe, and AMEA regions. Comprehensive...
Lilly eyes targeted cancer therapies with $1.4 billion Point Biopharma deal
Reuters via Yahoo Finance· 8 months ago(Reuters) -Eli Lilly and Co will buy Point Biopharma Global for $1.4 billion, the companies said on...
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting...
NewMediaWire via Yahoo Finance· 2 months agoFREMONT, CA - (NewMediaWire) - April 10, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a...
Much of biopharma industry yet to set climate impact targets - report
Reuters via Yahoo News· 2 years agoMuch of the global pharmaceutical and biotech industry has yet to set any targets for reducing...
YS Biopharma Co., Ltd. (NASDAQ:YS) Q3 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoYS Biopharma Co., Ltd. (NASDAQ:YS) Q3 2024 Earnings Call Transcript April 19, 2024 YS Biopharma Co.,...
Sharp plans Pennsylvania site expansion for secondary packaging
Packaging Gateway via Yahoo Finance· 1 month agoSharp Services, a provider of contract packaging and clinical supply services, has announced an...
Commission forges plan for European biopharma leadership – leak
Euronews via Yahoo News· 4 months agoThe EU executive is drafting a strategy designating biotech critical to the continent’s strategic...
Novo takes aim at obesity drug shortages with $6B manufacturing plan
BioPharma Dive via Yahoo Finance· 7 months agoDive Brief: Novo Nordisk plans to invest $6 billion to expand its drug manufacturing capacity as it...
Decoding Cardinal Health Inc (CAH): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 4 months agoCardinal Health Inc (NYSE:CAH) exhibits robust revenue growth with a 12% increase in the latest...
Why selling to Novartis made sense for Mariana
BioPharma Dive via Yahoo Finance· 1 month agoMariana Oncology arrived at the J.P. Morgan Healthcare Conference this past January with momentum. The radiopharmaceutical drug developer had secured...